BRASILIA, Jan 14 (Reuters) - Brazil's health regulator
Anvisa said on Thursday that it still requires further
documentation before it can approve emergency use requests for
COVID-19 vaccines developed by AstraZeneca PLC and China
Sinovac Biotech.
Anvisa has scheduled a meeting on Sunday to decide on the
fast-track approvals that would allow vaccination to get under
way in Brazil next week.
(Reporting by Anthony Boadle)